Your cart is empty
Add prompt packs to continue
This collection of prompts represents the definitive tool for the modern endocrinologist seeking to optimize their clinical practice and diagnostic accuracy. Each instruction has been designed under rigorous instructional design standards, allowing artificial intelligence to act as an expert consultant in the complex balance of the endocrine system, advanced diabetes management and the most challenging metabolic pathologies. By integrating these prompts into their workflow, specialists will be able to streamline the interpretation of complex data, personalize treatment plans based on the latest evidence, and improve patient communication. It is a strategic investment to raise the quality of care, guaranteeing ultra-specific responses that cover everything from neuroendocrinology to peripheral glandular dysfunctions with unprecedented depth.
100 resources included
He acts as a Senior Consultant in Endocrinology and Bone Mineral Metabolism. Your objective is to design a comprehensive and personalized clinical protocol for the safe administration of parenteral bisphosphonates (Zoledronic Acid or Ibandronate) for a patient with [SPECIFIC DIAGNOSIS: OSTEOPOROSIS/PAGET'S DISEASE/CANCER]. This protocol must be based on the most recent international guidelines (IOF, ESCEO, AACE) and adapted to the patient's clinical situation characterized by [AGE], [SEX] and [RELEVANT COMORBILITIES]. In the first section, perform a rigorous evaluation of the pre-treatment requirements. Details the minimum acceptable values of Estimated Glomerular Filtration Rate (eGFR) and levels of [SERUM CALCIUM] and [25-OH VITAMIN D]. Defines absolute and relative contraindications, placing special emphasis on oral health and the protocol for referral to dentistry to prevent osteonecrosis of the jaw (ONJ), adjusted to the patient's risk according to their [DENTAL HISTORY]. In the second section, thoroughly describe the infusion procedure for [SELECTED DRUG]. Includes instructions on the type of dilution (e.g. 100 ml of 0.9% saline), the exact infusion time to minimize nephrotoxicity, and hydration guidelines (pre and post). It incorporates a prophylactic medication scheme to mitigate the acute phase syndrome (fever, myalgia, arthralgia), specifying doses of [RECOMMENDED ANTIPYRETIC/ANALGESIC]. In the third section, establishes the post-infusion monitoring and follow-up plan. Indicates when kidney function and electrolyte tests should be repeated, and defines the time interval for the next Bone Densitometry (DXA) and evaluation of [MARKERS OF BONE TURNOVER: CTX/P1NP]. It ends with a list of alarm signs that the patient must report immediately and criteria for therapeutic success or need to change to [ALTERNATIVE THERAPY] after the defined treatment period. Presents the information in a technical way, structured by clear headings, using tables if necessary to facilitate reading by nursing staff and other medical specialists. The tone should be professional, precise and of high clinical relevance.
He acts as a Senior Endocrinologist specialized in Neuroendocrinology and Metabolism. Your objective is to carry out an in-depth clinical analysis and a comprehensive management proposal for a patient who presents with obesity associated with possible thyroid dysfunction. The evaluation should focus on the interconnection between the hypothalamic-pituitary-thyroid axis and the regulation of basal energy expenditure in the context of excess adiposity. First, interpret the following laboratory values provided: TSH of [TSH value], Free T4 of [FT4 value], Free T3 of [FT3 value], and anti-TPO Antibody levels of [anti-TPO value]. Determines whether the findings suggest clinical or subclinical hypothyroidism or if the mild elevation of TSH is a secondary consequence of the hyposecretion of leptin by adipose tissue, differentiating between cause and consequence in the patient's pathology. Second, it correlates the reported clinical symptoms: [describe symptoms such as fatigue, cold intolerance or bradycardia] with the degree of obesity defined by a BMI of [patient's BMI] and an abdominal circumference of [girth in cm]. Analyzes how the hypothyroid state affects postprandial thermogenesis and fatty acid oxidation, making weight loss difficult despite standard nutritional interventions. You should also consider the presence of [comorbidities such as insulin resistance or dyslipidemia]. Third, develop a personalized treatment plan. If it is decided to initiate or adjust therapy with Levothyroxine, calculate the theoretical dose based on ideal weight and not on total weight to avoid overdosing, considering the therapeutic objective of maintaining TSH in the [TSH target range] range. It includes specific recommendations on chrononutrition, supplementation with selenium or zinc if necessary, and the optimal type of exercise (strength vs. aerobic) to improve sensitivity to thyroid hormones at the peripheral level. Finally, it generates a structured clinical report that includes: 1. Accurate endocrine-metabolic diagnosis, 2. Pathophysiological justification for the difficulty in losing weight, 3. Pharmacological and non-pharmacological intervention plan, and 4. Follow-up schedule for re-evaluation of thyroid function and body composition in [number of weeks] weeks.
He acts as an endocrinologist expert in bone mineral metabolism with extensive experience in the management of pathologies of the parathyroid glands. Your task is to develop a comprehensive and personalized treatment protocol for a patient with a confirmed diagnosis of Primary Hypercalcemia (Primary Hyperparathyroidism), integrating the most recent clinical practice guidelines from the Endocrine Society and international consensus. Start by evaluating the biochemical profile provided: [Serum Calcium, Ionic Calcium and PTH Levels]. It classifies the severity of the condition (mild, moderate or hypercalcemic crisis) and defines whether the initial approach should be in-hospital with aggressive fluid therapy (isotonic saline), calcitonin and intravenous bisphosphonates, or whether it allows controlled outpatient management. Determine eligibility for surgical treatment (parathyroidectomy) based on consensus criteria for asymptomatic patients, such as: the patient's age [Patient Age], the degree of calcium elevation above the upper limit of normal, the presence of renal complications [Findings on Renal Ultrasound or Creatinine Clearance], and the involvement of bone mass according to [Bone Densitometry Results / T-score]. For pharmacological management in patients who do not meet surgical criteria or have contraindications for surgery, develop a detailed plan that includes the use of calcimimetics such as Cinacalcet to control calcium levels and the use of bisphosphonates or other antiresorptives to protect bone mineral density. Explains the recommended initial dosage, expected mechanism of action, and short- and long-term therapeutic goals. It concludes with a clinical follow-up scheme that specifies the frequency of laboratory tests (calcium, creatinine, phosphorus) and periodic imaging studies to monitor disease progression. Be sure to include recommendations on dietary calcium intake and optimizing Vitamin D levels in this specific context [Current 25-OH Vitamin D level].